Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/4/e012312.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850198622568710144 |
|---|---|
| author | Bi-Cheng Wang |
| author_facet | Bi-Cheng Wang |
| author_sort | Bi-Cheng Wang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-f785f80f09874ea99c086f26fef8bd2f |
| institution | OA Journals |
| issn | 2051-1426 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-f785f80f09874ea99c086f26fef8bd2f2025-08-20T02:12:49ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-04-0113410.1136/jitc-2025-012312Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancerBi-Cheng Wang0Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Chinahttps://jitc.bmj.com/content/13/4/e012312.full |
| spellingShingle | Bi-Cheng Wang Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer Journal for ImmunoTherapy of Cancer |
| title | Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer |
| title_full | Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer |
| title_fullStr | Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer |
| title_full_unstemmed | Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer |
| title_short | Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer |
| title_sort | bevacizumab combined with chemotherapy and anti pd 1 therapy for the first line treatment of previously untreated metastatic triple negative breast cancer |
| url | https://jitc.bmj.com/content/13/4/e012312.full |
| work_keys_str_mv | AT bichengwang bevacizumabcombinedwithchemotherapyandantipd1therapyforthefirstlinetreatmentofpreviouslyuntreatedmetastatictriplenegativebreastcancer |